Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Klingemann

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Hans-G. Klingemann, M.D., Ph.D. Interview by Vicki P. GlaserH G Klingemann
Leukemia & Lymphoma|December 1, 1992
Trying to overcome residual disease after bone marrow transplantation for hematologic malignanciesH G Klingemann
Critical Care Medicine|February 7, 2001
Mechanical ventilation for bone marrow transplant patients: when does it become futile?H G Klingemann
Fortschritte Der Medizin|March 14, 1985
[Interactions in the formation of a fibrin clot]H G Klingemann
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Immunotherapy with dendritic cells: coming of age?H G Klingemann
Journal of Hematotherapy & Stem Cell Research|March 29, 2001
Cellular therapy of cancer with natural killer cells: will it ever work?H G Klingemann
Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Cellular therapy: finishing the jobH G Klingemann
Cytotherapy|July 26, 2005
Natural killer cell-based immunotherapeutic strategiesH-G Klingemann
La Ricerca in Clinica E in Laboratorio|January 1, 1983
[Fibronectin]H G Klingemann
Progress in Clinical and Biological Research|January 1, 1990
Use of granulocyte-macrophage colony stimulating factor (GM-CSF) to support intensive chemotherapyH G Klingemann
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Hans-G. Klingemann, M.D., Ph.D. Interview by Vicki P. GlaserH G Klingemann
Leukemia & Lymphoma|December 1, 1992
Trying to overcome residual disease after bone marrow transplantation for hematologic malignanciesH G Klingemann
Critical Care Medicine|February 7, 2001
Mechanical ventilation for bone marrow transplant patients: when does it become futile?H G Klingemann
Fortschritte Der Medizin|March 14, 1985
[Interactions in the formation of a fibrin clot]H G Klingemann
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Immunotherapy with dendritic cells: coming of age?H G Klingemann
Journal of Hematotherapy & Stem Cell Research|March 29, 2001
Cellular therapy of cancer with natural killer cells: will it ever work?H G Klingemann
Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Cellular therapy: finishing the jobH G Klingemann
Cytotherapy|July 26, 2005
Natural killer cell-based immunotherapeutic strategiesH-G Klingemann
La Ricerca in Clinica E in Laboratorio|January 1, 1983
[Fibronectin]H G Klingemann
Progress in Clinical and Biological Research|January 1, 1990
Use of granulocyte-macrophage colony stimulating factor (GM-CSF) to support intensive chemotherapyH G Klingemann
Pageof 14